Inventor
SADOFF JERALD C
US28 patents
⚠️ This page may combine multiple inventors who share the name “SADOFF JERALD C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AERAS GLOBAL TB VACCINE FOUND
7 patentsUS7666656B2Feb 23, 2010
Recombinant BCG strains with enhanced ability to escape the endosome
AERAS GLOBAL TB VACCINE FOUND17 citations90
US7829104B2Nov 9, 2010
Electroporation of Mycobacterium and overexpression of antigens in mycobacteria
AERAS GLOBAL TB VACCINE FOUND11 citations82
US7670609B2Mar 2, 2010
Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease
AERAS GLOBAL TB VACCINE FOUND16 citations79
US7625572B2Dec 1, 2009
Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria
AERAS GLOBAL TB VACCINE FOUND4 citations60
US8361482B2Jan 29, 2013
Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease
AERAS GLOBAL TB VACCINE FOUND4 citations58
US7608256B2Oct 27, 2009
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
AERAS GLOBAL TB VACCINE FOUND3 citations58
US8658136B2Feb 25, 2014
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
AERAS GLOBAL TB VACCINE FOUND0 citations47
US ARMY
6 patentsUS5824538AOct 20, 1998
Shigella vector for delivering DNA to a mammalian cell
US ARMY174 citations96
US4285936AAug 25, 1981
Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa
US ARMY52 citations92
US6410012B1Jun 25, 2002
Antimicrobial mediated bacterial DNA delivery
US ARMY42 citations88
US6872398B2Mar 29, 2005
Conjugate vaccine against gram-negative bacterial infections
US ARMY13 citations78
US7235234B1Jun 26, 2007
Bacterial delivery system
US ARMY8 citations71
US7045336B1May 16, 2006
Bacterial delivery system
US ARMY6 citations71
AERAS GLOBAL TB VACCINE FOUNDATION
4 patentsUS8043857B2Oct 25, 2011
Recombinant BCG strains with enhanced ability to escape the endosome
AERAS GLOBAL TB VACCINE FOUNDATION4 citations59
US8053568B2Nov 8, 2011
Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof
AERAS GLOBAL TB VACCINE FOUNDATION1 citations46
US7935354B2May 3, 2011
Generation of new BCG vaccine strains protecting against the establishment of latent Mycobacterium tuberculosis infection and reactivation from the latent or persistent state
AERAS GLOBAL TB VACCINE FOUNDATION1 citations46
US7883696B2Feb 8, 2011
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
AERAS GLOBAL TB VACCINE FOUNDATION0 citations46
JANSSEN PHARMACEUTICALS INC
2 patentsUS11498944B2Nov 15, 2022
Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines
JANSSEN PHARMACEUTICALS INC10 citations81
US11384122B2Jul 12, 2022
Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines
JANSSEN PHARMACEUTICALS INC2 citations68